JP:4569 Stock Latest News
Company AnnouncementsKopernik Global Investors Lifts Stake in KYORIN Pharmaceutical to Over 10%1w ago4569
Company AnnouncementsKyorin to Divest Generic Drug Unit to New PCPI Platform, Sharpen Focus on New Drugs1M ago4569
Company AnnouncementsKYORIN to Promote World’s First Cream Treatment for Allergic Conjunctivitis in Partnership with Santen3M ago4569
Company AnnouncementsKYORIN Pharmaceutical Details Q1 Results and Pipeline Outlook for FY20273M ago4569
Company AnnouncementsKYORIN Pharmaceutical Warns of Profit Slump and Dividend Cut Despite Strong Balance Sheet3M ago4569
Company AnnouncementsKYORIN, Santen Team Up to Expand Marketing of Novel Allergic Conjunctivitis Cream in Japan3M ago4569Company AnnouncementsKYORIN Expands Performance-Linked Stock Compensation Plan to Corporate Officers5M ago4569
Company AnnouncementsKYORIN Pharmaceutical Reshapes Board and Audit Team in June Leadership Overhaul5M ago4569
Company AnnouncementsKYORIN Sets Aggressive Investment Plan in New Medium-Term Strategy “Vision 110 – Stage 2 –”5M ago4569
Company AnnouncementsKYORIN Pharmaceutical Misses Interim Profit Forecasts on Weaker Sales and Higher R&D Costs5M ago4569
Company AnnouncementsKYORIN Pharmaceutical Announces Consolidated Results and Outlook for FY20255M ago4569
Company AnnouncementsKyorin Pharmaceutical Slashes Profit Outlook and Plans Dividend Cut After Sharp Earnings Decline5M ago4569Company AnnouncementsKyorin to Transfer Generic Drug Operations to Co-Creation Platform with Daito6M ago4569
Company AnnouncementsKYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets7M ago4569
Company AnnouncementsKYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO7M ago4569
Company AnnouncementsKyorin Pharma Overhauls Governance With New Mandate-Based Officer System8M ago4569
Company AnnouncementsKYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit9M ago4569
Company AnnouncementsKYORIN Pharma Releases Nine-Month Consolidated Results and Outlook9M ago4569
Company AnnouncementsKYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook9M ago4569Company AnnouncementsKYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East10M ago4569
